1-3 of 3
Mark Cook, PhD FRCPath
Close
Sort by
Journal Articles

Subcutaneous PAD As Induction Therapy for Patients with Newly Diagnosed Myeloma: A Phase 2 Trial Assessing the Impact of Minimal Residual Disease (MRD) in Patients with Deferred Autologous Stem Cell Transplantation (PADIMAC)

Rakesh Popat, James D Cavenagh, MD, Roger G Owen, MD, Matthew Streetly, Stephen A Schey, MD, Mickey Koh, MD, Josephine Crowe, Michael F. Quinn, FRCPath, MB, MD MRCP, Shirley D'Sa, MD FRCP, FRCPath, Andres Virchis, Gordon Cook, MD PhD, Charles Crawley, Guy Pratt, Mark Cook, PhD FRCPath, Heather E. Oakervee, MBBS, BSc, MD MRCP, FRCPath, Nicholas Counsell, Toyin Adedayo, Alison Evans, Nivette Braganca, Paul Smith, MSc, Janet lyons-Lewis, Neil Rabin, Kwee L Yong, MBChB, PhD
Journal: Blood
Blood (2014) 124 (21): 4745.
https://doi.org/10.1182/blood.V124.21.4745.4745
Published: 2014
Journal Articles

Transfusion of CMV Seronegative T-Deplete Allogeneic Stem Cell Transplant Recipients with CMV Unselected Blood Products Confers a Zero Risk of CMV Transmission in the Era of Universal Leucodepletion: A UK Single-Centre Experience

Suzanne Hall, MB BCh, FRCPath, Sandeep Nagra, MBChB, Husam Osman, MB BCh, Mark Cook, PhD FRCPath, Charles F. Craddock, BM, MRCP, MRCPath, Sridhar Chaganti, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2894.
https://doi.org/10.1182/blood.V124.21.2894.2894
Published: 2014
Journal Articles

Serum Free Light Chain Assays in the Early Detection of Cast Nephropathy in Patients Presenting with Unexplained Acute Kidney Injury (AKI): Results from a Pharmacoeconomic Evaluation

Mark Cook, PhD FRCPath, Paul Cockwell, Christine Almond, Holly Cranmer, Stephen Harding, MDPhD, Richard Hughes, Chris Knight, Alexander Hirst
Journal: Blood
Blood (2014) 124 (21): 2612.
https://doi.org/10.1182/blood.V124.21.2612.2612
Published: 2014